NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)
$71.89 0.4825 (0.6757%)
Analysed NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) News Sources
CF & POET Partner to Advance Low-Carbon Pathway for U.S. Ethanol
27-01-2026
yahoo.com
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
03-02-2026
yahoo.com
CENX's Hawesville Site Sale to Facilitate AI Data Campus Buildout
04-02-2026
yahoo.com
Cabot Expands Mexico Footprint With MXCB Facility Buyout
05-02-2026
yahoo.com
Synthetic Biology and Bioprocessing Market Reaches Multi-Billion Scale with High-Throughput Fermentation and Engineered Microbes Driving Innovation
09-02-2026
yahoo.com
Is Novozymes (CPSE:NSIS B) Pricing Reflect Recent Valuation Concerns Accurately
16-02-2026
yahoo.com
Novonesis (Novozymes) B (NVZMF) (H1 2026) Earnings Call Highlights: Raises Guidance on 8% ...
20-08-2026
yahoo.com
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
16-04-2026
yahoo.com
FUL vs. NVZMY: Which Stock Is the Better Value Option?
07-08-2026
yahoo.com
FUL or NVZMY: Which Is the Better Value Stock Right Now?
24-08-2026
yahoo.com
What is the current price of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The current price of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is $71.89.
NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) since the previous trading day is $0.4825.
NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) since the previous trading day is 0.6757%.
What is the most recent average sentiment score for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The most recent average sentiment score for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is 50 out of 100.
What is the most recent average sentiment for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)?
The most recent sentiment for NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS) is .
SEC-8K** Filing Available For NOVONESIS (NOVOZYMES)-ADR (NVZMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.